Results 181 to 190 of about 578,179 (195)

Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain

Immunological Reviews, 2009
Anna Berglöf, Mauno Vihinen, Beston F Nore   +2 more
exaly  

Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-]pyrimidine tyrosine kinase inhibitors

Biochemical Pharmacology, 2000
Alan J Kraker, A J Kraker, H D Showalter
exaly  

Raman Microspectroscopic Evidence for the Metabolism of a Tyrosine Kinase Inhibitor, Neratinib, in Cancer Cells

Angewandte Chemie - International Edition, 2018
Samir F El-Mashtoly, Klaus Gerwert, Hesham K. Yosef   +2 more
exaly  

Association of the tyrosine kinase LCK with phospholipase C-gamma 1 after stimulation of the T cell antigen receptor.

Journal of Experimental Medicine, 1992
J B Imboden, M Y Han, T Pawson
exaly  

Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?

Trends in Endocrinology and Metabolism, 2015
Athanasios Fountas, Agathocles Tsatsoulis   +1 more
exaly  

Clinical pharmacokinetics of tyrosine kinase inhibitors

Cancer Treatment Reviews, 2009
Hans J. Gelderblom, Henk-Jan Guchelaar, Nielka P van Erp   +2 more
exaly  

Sustained Activation of Lyn Tyrosine Kinase In Vivo Leads to Autoimmunity

Journal of Experimental Medicine, 2002
David M Tarlinton, Jane Armes, Margaret Hibbs   +2 more
exaly  

Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

EMBO Journal, 1997
Stevan R Hubbard
exaly  

A new method for isolating tyrosine kinase substrates used to identify Fish, an SH3 and PX domain‐containing protein, and Src substrate

EMBO Journal, 1998
Sara A Courtneidge, Peter Lock, Toby Gibson   +2 more
exaly  

Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Ca-A Cancer Journal for Clinicians
Kaushal Parikh, Jair Bar, Claudio De Vito   +2 more
exaly